• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效抗逆转录病毒治疗中断期间HIV-1的动态变化与演变

Dynamics and evolution of HIV-1 during structured treatment interruptions.

作者信息

Frost Simon D W

机构信息

Department of Pathology, School of Medicine, University of California, San Diego, USA.

出版信息

AIDS Rev. 2002 Jul-Sep;4(3):119-27.

PMID:12416446
Abstract

Our understanding of the way in which HIV responds to highly active antiretroviral therapy (HAART) has benefited greatly from the use of mathematical models of viral dynamics and evolution. In this paper, I review the role that these models may play in the design and analysis of studies of structured treatment interruptions (STIs). STIs are being investigated in several different contexts: to reduce drug toxicities; to boost HIV-specific immune responses; and to allow reversion of drug resistance mutations in highly drug-experienced patients. I illustrate how models can help to compare the dynamics and evolution of HIV in these different scenarios, and to assess the risks and benefits of STIs.

摘要

我们对人类免疫缺陷病毒(HIV)如何应对高效抗逆转录病毒疗法(HAART)的理解,很大程度上得益于病毒动力学和进化的数学模型的应用。在本文中,我将回顾这些模型在结构化治疗中断(STIs)研究的设计和分析中可能发挥的作用。目前正在多种不同背景下对结构化治疗中断进行研究:以降低药物毒性;增强HIV特异性免疫反应;以及使有丰富用药经验的患者体内的耐药突变发生逆转。我将举例说明模型如何有助于比较HIV在这些不同情况下的动力学和进化情况,并评估结构化治疗中断的风险和益处。

相似文献

1
Dynamics and evolution of HIV-1 during structured treatment interruptions.高效抗逆转录病毒治疗中断期间HIV-1的动态变化与演变
AIDS Rev. 2002 Jul-Sep;4(3):119-27.
2
Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.在接受双核苷类似物治疗后接受高效抗逆转录病毒治疗的患者中,CD4细胞计数引导下的结构化治疗中断后出现耐药性HIV的情况。
Clin Infect Dis. 2005 Mar 1;40(5):728-34. doi: 10.1086/427878. Epub 2005 Feb 4.
3
Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.成功抗逆转录病毒治疗短期、无结构中断的免疫病毒学后果及安全性
J Infect. 2007 Feb;54(2):159-66. doi: 10.1016/j.jinf.2006.03.029. Epub 2006 May 11.
4
Predicting differential responses to structured treatment interruptions during HAART.预测高效抗逆转录病毒治疗期间对结构化治疗中断的不同反应。
Bull Math Biol. 2004 Sep;66(5):1093-118. doi: 10.1016/j.bulm.2003.11.003.
5
Treatment interruptions in HIV-infected subjects.HIV感染受试者的治疗中断情况。
J Antimicrob Chemother. 2006 Sep;58(3):502-5. doi: 10.1093/jac/dkl268. Epub 2006 Jul 1.
6
Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.尽管病毒发生了进化且耐药基因型的选择非常有限,但高效抗逆转录病毒疗法仍能长期抑制血浆病毒血症。
J Med Virol. 2004 Jul;73(3):350-61. doi: 10.1002/jmv.20098.
7
Persistence of HIV-1 drug resistance mutations and emergence during antiretroviral treatment interruption: considerations from a clinical case.抗逆转录病毒治疗中断期间HIV-1耐药性突变的持续存在及出现:来自一个临床病例的思考
Med Sci Monit. 2003 Apr;9(4):CS16-9.
8
Drug resistance mutations during structured treatment interruptions.结构化治疗中断期间的耐药性突变
Antivir Ther. 2003 Oct;8(5):411-5.
9
HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.单次治疗中断后HIV-1病毒反弹动力学取决于高效抗逆转录病毒疗法开始的时间。
AIDS. 2008 Aug 20;22(13):1583-8. doi: 10.1097/QAD.0b013e328305bd77.
10
Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients.司他夫定/替诺福韦联合治疗在接受过高效抗逆转录病毒治疗的患者中的抗病毒疗效及基因型耐药模式
Antivir Ther. 2006;11(2):233-43.

引用本文的文献

1
Exploring the Human Microbiome: The Potential Future Role of Next-Generation Sequencing in Disease Diagnosis and Treatment.探索人类微生物组:下一代测序在疾病诊断和治疗中的潜在未来作用。
Front Immunol. 2019 Jan 7;9:2868. doi: 10.3389/fimmu.2018.02868. eCollection 2018.
2
Costs versus benefits: best possible and best practical treatment regimens for HIV.成本与效益:针对艾滋病毒的最佳可行治疗方案和最佳实际治疗方案
J Math Biol. 2007 Mar;54(3):385-406. doi: 10.1007/s00285-006-0059-1. Epub 2007 Jan 5.
3
Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic hiv infection during structured treatment interruptions.
在接受结构化治疗中断的慢性HIV感染患者中,p24抗原血症与1型人类免疫缺陷病毒(HIV)RNA水平之间缺乏患者内纵向相关性。
J Clin Microbiol. 2004 Apr;42(4):1620-5. doi: 10.1128/JCM.42.4.1620-1625.2004.